Tachi Y - Search Results

1

Diagnostic performance of real-time tissue elastography in chronic hepatitis C patients with sustained virological response.

Tachi Y, Hirai T, Kojima Y, Tachino H, Hosokawa C, Ohya T, Yasue Y, Kurokawa Y, Torii Y, Yamamoto S, Matsuura H, Kobayashi T, Miyoshi H, Inui K, Katano Y. Tachi Y, et al. Eur J Gastroenterol Hepatol. 2020 May;32(5):609-615. doi: 10.1097/MEG.0000000000001539. Eur J Gastroenterol Hepatol. 2020. PMID: 31688308

2

Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.

Tachi Y, Katano Y, Honda T, Hayashi K, Ishigami M, Itoh A, Hirooka Y, Nakano I, Samejima Y, Goto H. Tachi Y, et al. Liver Int. 2010 Apr;30(4):554-9. doi: 10.1111/j.1478-3231.2009.02164.x. Epub 2009 Nov 27. Liver Int. 2010. PMID: 19951380

3

Prevalence of hepatitis C virus genotype 1a in Japan and correlation of mutations in the NS5A region and single-nucleotide polymorphism of interleukin-28B with the response to combination therapy with pegylated-interferon-alpha 2b and ribavirin.

Hayashi K, Katano Y, Kuzuya T, Tachi Y, Honda T, Ishigami M, Itoh A, Hirooka Y, Ishikawa T, Nakano I, Urano F, Yoshioka K, Toyoda H, Kumada T, Goto H. Hayashi K, et al. Among authors: tachi y. J Med Virol. 2012 Mar;84(3):438-44. doi: 10.1002/jmv.23207. J Med Virol. 2012. PMID: 22246829

4

Progressive fibrosis significantly correlates with hepatocellular carcinoma in patients with a sustained virological response.

Tachi Y, Hirai T, Miyata A, Ohara K, Iida T, Ishizu Y, Honda T, Kuzuya T, Hayashi K, Ishigami M, Goto H. Tachi Y, et al. Hepatol Res. 2015 Jan;45(2):238-46. doi: 10.1111/hepr.12331. Epub 2014 Apr 24. Hepatol Res. 2015. PMID: 24655233

5

Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C Virus.

Tachi Y, Hirai T, Toyoda H, Tada T, Hayashi K, Honda T, Ishigami M, Goto H, Kumada T. Tachi Y, et al. PLoS One. 2015 Jul 27;10(7):e0133515. doi: 10.1371/journal.pone.0133515. eCollection 2015. PLoS One. 2015. PMID: 26214180 Free PMC article.

6

Clinical characteristics and molecular analysis of hepatitis B virus reactivation in hepatitis B surface antigen-negative patients during or after immunosuppressive or cytotoxic chemotherapy.

Hayashi K, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Tachi Y, Ishikawa T, Katano Y, Yoshioka K, Toyoda H, Kumada T, Goto H, Hirooka Y. Hayashi K, et al. Among authors: tachi y. J Gastroenterol. 2016 Nov;51(11):1081-1089. doi: 10.1007/s00535-016-1187-z. Epub 2016 Mar 4. J Gastroenterol. 2016. PMID: 26943169

7

α-fetoprotein levels after interferon therapy predict regression of liver fibrosis in patients with sustained virological response.

Tachi Y, Hirai T, Ishizu Y, Honda T, Kuzuya T, Hayashi K, Ishigami M, Goto H. Tachi Y, et al. J Gastroenterol Hepatol. 2016 May;31(5):1001-8. doi: 10.1111/jgh.13245. J Gastroenterol Hepatol. 2016. PMID: 27123974

8

Liver stiffness measurement using acoustic radiation force impulse elastography in hepatitis C virus-infected patients with a sustained virological response.

Tachi Y, Hirai T, Kojima Y, Miyata A, Ohara K, Ishizu Y, Honda T, Kuzuya T, Hayashi K, Ishigami M, Goto H. Tachi Y, et al. Aliment Pharmacol Ther. 2016 Aug;44(4):346-55. doi: 10.1111/apt.13695. Epub 2016 Jun 13. Aliment Pharmacol Ther. 2016. PMID: 27291657

9

Liver fibrosis indices for identifying patients at low risk of developing hepatocellular carcinoma after eradication of HCV.

Toyoda H, Tada T, Tachi Y, Hirai T, Yasuda S, Honda T, Hayashi K, Ishigami M, Goto H, Kumada T. Toyoda H, et al. Among authors: tachi y. Antivir Ther. 2017;22(3):185-193. doi: 10.3851/IMP3081. Epub 2016 Sep 2. Antivir Ther. 2017. PMID: 27586087

10

Efficacy and tolerability of an IFN-free regimen with DCV/ASV for elderly patients infected with HCV genotype 1B.

Toyoda H, Kumada T, Tada T, Shimada N, Takaguchi K, Senoh T, Tsuji K, Tachi Y, Hiraoka A, Ishikawa T, Shima T, Okanoue T. Toyoda H, et al. Among authors: tachi y. J Hepatol. 2017 Mar;66(3):521-527. doi: 10.1016/j.jhep.2016.11.012. Epub 2016 Nov 25. J Hepatol. 2017. PMID: 27890790 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters